Every story in this section, newest first — page 277 of 373.
HP (NYSE:HPQ) reported fiscal first-quarter results on Tuesday that exceeded Wall Street’s expectations, fueled by a resurgence in personal computing and the early rollout of AI-enabled devices.
Lucid Group (NASDAQ:LCID) shares faced pressure in after-hours trading Tuesday after the company issued 2026 production guidance that trailed Wall Street estimates, overshadowing a record quarter for vehicle deliveries.
MediaAlpha (NYSE:MAX) shares jumped 13.1% Tuesday morning as investors looked past a slight revenue miss to focus on a massive spike in profitability and an optimistic outlook for the 2026 fiscal year.
Tesla's (NASDAQ:TSLA) grip on the European electric vehicle market is showing signs of significant strain as new registration data reveals a sharp divergence between the U.S. automaker and its Chinese rivals.
Albany International (NYSE:AIN) reported fourth-quarter results on Tuesday that exceeded revenue forecasts, as the company moved to streamline its portfolio by launching a strategic review of its structures assembly business.
Shoals Technologies Group (NASDAQ:SHLS) reported fourth-quarter revenue that surpassed Wall Street forecasts, fueled by a record backlog and a significant pivot into the battery energy storage (BESS) market.
Warner Bros. Discovery (NASDAQ:WBD) confirmed Tuesday that it has received a revised acquisition proposal from Paramount Skydance, marking a dramatic escalation in the battle for Hollywood’s most storied studio and its massive library of IP.
Leonardo DRS (NASDAQ:DRS) reported fourth-quarter and full-year 2025 results that comfortably cleared Wall Street estimates, propelled by a "net non-routine" boost from quantum computing technology licensing and surging demand for tactical radars and naval propulsion.
Oak Brook, Illinois-based Portillo’s (NASDAQ:PTLO), the fast-casual restaurant chain known for Chicago-style hot dogs, Italian beef sandwiches and chocolate cake, reported fourth-quarter and fiscal 2025 financial results.
Fidelity National Information Services (NYSE:FIS) reported a strong fiscal year 2025, meeting its financial targets and signaling a new phase of growth following the successful completion of its structural reorganization.
Repligen (NASDAQ:RGEN) reported fourth-quarter results that surpassed analyst forecasts, providing fresh evidence that the bioprocessing industry is successfully moving past its post-pandemic destocking phase.
Houston-based Westlake Chemical Partners (NYSE:WLKP), the master limited partnership that owns a 13.3% limited partner interest in Westlake Chemical OpCo LP, which operates ethylene production facilities, reported fourth-quarter and full-year 2025 financial results on February 24, 2026.
China Yuchai International (NYSE:CYD) reported a significant expansion in its fiscal 2025 results, as a recovery in China’s commercial vehicle sector and a shift toward high-horsepower engines drove record unit sales and margin expansion.
Coca-Cola FEMSA (NYSE:KOF) reported a sharp rise in fourth-quarter profitability, as the bottling giant leaned on price increases and digital distribution initiatives to overcome volume sluggishness in key North American markets.
CECO Environmental (NASDAQ:CECO), a provider of engineered solutions for air pollution control, industrial ventilation and fluid handling, reported strong fourth-quarter and full-year 2025 financial results.
Ferguson Enterprises (NYSE:FERG), a leading distributor of plumbing and heating products, infrastructure and industrial supplies in North America, reported strong full-year 2025 financial results
Life Time Group Holdings (NYSE:LTH) reported record financial results for fiscal 2025, buoyed by a surge in high-margin membership dues and increased in-center spending.
Orthofix Medical (NASDAQ:OFIX) delivered a pivotal fourth quarter to close out fiscal 2025, reaching a long-sought milestone of positive annual free cash flow while reporting a 10% jump in its global spine fixation business.
Fulcrum Therapeutics (NASDAQ:FULC) reported fourth-quarter and full-year 2025 results highlighted by positive 12-week data for its lead candidate, pociredir.
Beam Therapeutics (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, reported fourth-quarter and full-year 2025 financial results on February 24, 2026.
Alpharetta, Georgia-based Avanos Medical (NYSE:AVNS), a medical technology company focused on pain management and chronic care solutions, reported fourth-quarter and full-year 2025 financial results on February 24, 2026.
Atlanta-based Havertys Furniture Companies (NYSE:HVT), a leading regional retailer of residential furniture and accessories, reported solid fourth-quarter and full-year 2025 financial results on February 24, 2026.
Xometry (NASDAQ:XMTR) reported a record-breaking fourth quarter to cap a year of significant operational inflection, as the company’s AI-native marketplace officially established a trajectory of sustained profitability on an adjusted basis.
American Tower (NYSE:AMT) reported a resilient finish to fiscal 2025, driven by record fourth-quarter revenue and robust demand for its distributed real estate.
